A phase 3 trial reveals that combining brentuximab vedotin with lenalidomide and rituximab improves survival in relapsed ...

On Astellas Pharma’s mission to develop new cell therapies in cancers and other diseases, not all candidates are destined to ...

Tevimbra is under clinical development by BeiGene and currently in Phase II for Marginal Zone B-cell Lymphoma.

Research shows routine follow-up misses most relapses in lymphoma patients in remission, highlighting the need for improved ...

"Imugene doses first Australian subject in trial of B-cell lymphoma drug candidate" was originally created and published by ...

XYF-19 is under clinical development by Xi'An Yufan Biotechnology and currently in Phase I for Diffuse Large B-Cell Lymphoma.

Navi Mumbai: In a medical breakthrough at Kokilaben Dhirubhai Ambani Hospital, Navi Mumbai, a 39-year-old Rijesh Nair, a ...

Caribou Biosciences, Inc. data from phase 1 ANTLER study is expected in 1H 2025. Click here to find out why I'm neutral on ...

As we start the New Year, it’s time to schedule your annual wellness visit. This important appointment is to talk about any ...

In recent years, the FDA has amped up its supervision of accelerated approvals, including by requiring that confirmatory ...

Researchers sought to determine whether patients with PMBCL may be able to forgo irradiation therapy during consolidation.